Skip to content

A Randomized Controlled Study on the influenza like patients with Atomized Inhalation of Plasma Activated Water

A Randomized Controlled Study on the influenza like symptoms with Atomized Inhalation of Plasma Activated Water

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095874
Enrollment
Unknown
Registered
2025-01-14
Start date
2025-01-20
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza

Interventions

Sponsors

The 986th Air Force hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Age >= 18 years, gender unlimited; (2) The clinical diagnosis is influenza, and within 3 days of onset; a. Fever >= 38 ? (axillary) during pre dose examination or within 4 hours after taking antipyretics; b. At least one of the following systemic and respiratory symptoms related to influenza (excluding chronic symptoms that existed within 30 days before the onset of influenza) is moderate or above in severity: Systemic symptoms (headache, fever or chills, muscle soreness or fatigue) Respiratory symptoms (cough, sore throat or nasal congestion) (3) The patient agreed to participate in this trial and signed the informed consent.

Exclusion criteria

Exclusion criteria: (1) Use of anti influenza drugs; (2) Patients with severe influenza virus infection requiring hospitalization; (3) Patients with serious basic diseases accompanied by important organs such as heart, lung, liver and kidney; (4) Patients with severe systemic infection and malignant tumor; (5) High sensitivity constitution, including allergic bronchial asthma; (6) Patients with mental disorders; (7) Pregnant, lactating or preparing for pregnancy; (8) Subjects considered by the investigator as unsuitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
The time to alleviation of influenza symptoms;Adverse event;

Secondary

MeasureTime frame
Nucleic acid conversion rate;Co-medication rate;

Countries

China

Contacts

Public ContactBinghua Zhang

The 986th Air Force hospital

13572559968@qq.com+86 135 7255 9968

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026